TVTX
Travere Therapeutics, Inc.
Travere Therapeutics, Inc. (TVTX) has 10 SEC Form 4 filings (30 transaction rows) in the rolling window, disclosed by 9 distinct insiders. Most recent filing: Jun 22, 2026.
The most active filer is Chief Legal Officer and GC REED ELIZABETH E with 3 filings. Insiders have net sold $4.0M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Eric Dube
- Employees:385
- HQ:San Diego, CA, US
- IPO:2012-11-08
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$6.4M
reported sales (SEC code S)
Unique Insiders
9
in the rolling window
Market Cap
$5.3B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Baynes Roy D.First in 6 months | Director | Sale | 4,500 | $210K | May 7 | SEC ↗ |
Meckler Jeffrey AFirst filing | Director | Sale | 8,000 | $360K | May 7 | SEC ↗ |
ROTE WILLIAM E.First filing | Chief Research Officer | Sale | 2,763 | $121K | May 7 | SEC ↗ |
REED ELIZABETH EFirst filing | Chief Legal Officer and GC | Sale | 20,000 | $900K | May 7 | SEC ↗ |
REED ELIZABETH EFirst filing | Chief Legal Officer and GC | Sale | 2,174 | $101K | May 7 | SEC ↗ |
REED ELIZABETH EFirst filing | Chief Legal Officer and GC | Sale | 2,076 | $91K | May 7 | SEC ↗ |
Inrig JulaFirst filing | CHIEF MEDICAL OFFICER | Sale | 20,000 | $900K | May 7 | SEC ↗ |
Inrig JulaFirst filing | CHIEF MEDICAL OFFICER | Sale | 2,174 | $101K | May 7 | SEC ↗ |
Inrig JulaFirst filing | CHIEF MEDICAL OFFICER | Sale | 311 | $14K | May 7 | SEC ↗ |
Heerma PeterFirst filing | CHIEF COMMERCIAL OFFICER | Sale | 2,174 | $101K | May 7 | SEC ↗ |
Dube Eric MFirst filing | CHIEF EXECUTIVE OFFICER | Sale | 22,500 | $989K | May 7 | SEC ↗ |
Cline Christopher R.First filing | CHIEF FINANCIAL OFFICER | Sale | 2,181 | $102K | May 7 | SEC ↗ |
Cline Christopher R.First filing | CHIEF FINANCIAL OFFICER | Sale | 310 | $14K | May 7 | SEC ↗ |
Calvin SandraFirst filing | SVP, CHIEF ACCOUNTING OFFICER | Sale | 67,115 | $2.4M | Nov 6 | SEC ↗ |
Related companies
Travere Therapeutics, Inc. is in the Healthcare sector.